| 2024-08-26 |
Modalis Therapeutics Corporation4883 |
Position 585,700 shares |
Ratio 1.2900% |
▼0.0801%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2024-08-05 |
Modalis Therapeutics Corporation4883 |
Position 585,700 shares |
Ratio 1.3700% |
▼0.1100%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2024-07-17 |
CellSeed Inc.7776 |
Position 166,670 shares |
Ratio 0.4800% |
▼0.4100%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2024-07-02 |
Modalis Therapeutics Corporation4883 |
Position 585,700 shares |
Ratio 1.4800% |
▼0.1101%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2024-04-17 |
Modalis Therapeutics Corporation4883 |
Position 585,700 shares |
Ratio 1.5900% |
▼0.1600%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2024-03-05 |
CellSeed Inc.7776 |
Position 287,870 shares |
Ratio 0.8900% |
▼0.0201%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-12-29 |
SanBio Company Limited4592 |
Position 328,200 shares |
Ratio 0.4900% |
▼0.0301%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-12-27 |
Modalis Therapeutics Corporation4883 |
Position 585,700 shares |
Ratio 1.7500% |
▼0.1001%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-12-06 |
Delta-Fly Pharma,Inc.4598 |
Position 114,900 shares |
Ratio 1.3900% |
▼0.3101%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-11-22 |
Delta-Fly Pharma,Inc.4598 |
Position 114,900 shares |
Ratio 1.7000% |
▲0.3100%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-11-15 |
Delta-Fly Pharma,Inc.4598 |
Position 114,900 shares |
Ratio 1.3900% |
▼0.4101%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-11-08 |
CellSeed Inc.7776 |
Position 287,870 shares |
Ratio 0.9100% |
▲0.1200%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-11-02 |
CellSeed Inc.7776 |
Position 248,470 shares |
Ratio 0.7900% |
▼0.0800%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-08-25 |
CellSeed Inc.7776 |
Position 248,470 shares |
Ratio 0.8700% |
▲0.2400%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-08-24 |
CellSeed Inc.7776 |
Position 179,070 shares |
Ratio 0.6300% |
▲0.1200%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-08-23 |
CellSeed Inc.7776 |
Position 147,370 shares |
Ratio 0.5100% |
▲0.1300%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-07-24 |
Modalis Therapeutics Corporation4883 |
Position 585,700 shares |
Ratio 1.8500% |
▲0.1600%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-07-21 |
Modalis Therapeutics Corporation4883 |
Position 534,400 shares |
Ratio 1.6900% |
▲0.1799%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-07-11 |
Modalis Therapeutics Corporation4883 |
Position 478,100 shares |
Ratio 1.5100% |
▲0.0600%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-07-07 |
Modalis Therapeutics Corporation4883 |
Position 458,200 shares |
Ratio 1.4500% |
▲0.1199%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-07-05 |
Modalis Therapeutics Corporation4883 |
Position 421,500 shares |
Ratio 1.3300% |
▲0.0700%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-07-03 |
Modalis Therapeutics Corporation4883 |
Position 397,900 shares |
Ratio 1.2600% |
▲0.1499%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-06-29 |
Modalis Therapeutics Corporation4883 |
Position 351,600 shares |
Ratio 1.1100% |
▲0.1300%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-06-28 |
Modalis Therapeutics Corporation4883 |
Position 311,200 shares |
Ratio 0.9800% |
▲0.0999%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-06-27 |
Modalis Therapeutics Corporation4883 |
Position 272,500 shares |
Ratio 0.8800% |
▲0.1600%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-06-23 |
Modalis Therapeutics Corporation4883 |
Position 223,200 shares |
Ratio 0.7200% |
▲0.1699%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-06-22 |
Modalis Therapeutics Corporation4883 |
Position 170,600 shares |
Ratio 0.5500% |
▲0.1200%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-05-18 |
Delta-Fly Pharma,Inc.4598 |
Position 114,900 shares |
Ratio 1.8000% |
▲0.1600%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-05-16 |
Delta-Fly Pharma,Inc.4598 |
Position 104,800 shares |
Ratio 1.6400% |
▲0.0699%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-04-28 |
SanBio Company Limited4592 |
Position 337,300 shares |
Ratio 0.5200% |
▲0.1000%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-03-01 |
Delta-Fly Pharma,Inc.4598 |
Position 100,500 shares |
Ratio 1.5700% |
▲0.0900%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-02-28 |
Delta-Fly Pharma,Inc.4598 |
Position 94,300 shares |
Ratio 1.4800% |
▲0.1000%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-02-01 |
Delta-Fly Pharma,Inc.4598 |
Position 88,300 shares |
Ratio 1.4200% |
▲0.0699%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-01-20 |
Delta-Fly Pharma,Inc.4598 |
Position 79,200 shares |
Ratio 1.2700% |
▲0.1300%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-01-13 |
Delta-Fly Pharma,Inc.4598 |
Position 71,000 shares |
Ratio 1.1400% |
▲0.1099%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-01-12 |
Delta-Fly Pharma,Inc.4598 |
Position 63,800 shares |
Ratio 1.0300% |
▲0.0800%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-01-11 |
Delta-Fly Pharma,Inc.4598 |
Position 59,400 shares |
Ratio 0.9500% |
▲0.1200%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-01-10 |
Delta-Fly Pharma,Inc.4598 |
Position 52,000 shares |
Ratio 0.8300% |
▲0.0999%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|
| 2023-01-06 |
Delta-Fly Pharma,Inc.4598 |
Position 44,500 shares |
Ratio 0.7300% |
▲0.1300%
|
Arrowstreet (Canada) Global All-Country Alpha Extension Fund I
|